India identifies Brazilian, South African Covid variants

Details All patients with new strain of COVID-19 their contacts quarantined

Details All patients with new strain of COVID-19 their contacts quarantined

"We have not returned the AstraZeneca vaccines to India", WION quoted South Africa's Health Minister Dr Zweli Mkhize as saying.

The jabs, only recently approved by the national health products authority, are expected to be distributed to various vaccination centres overnight. The vaccine will be rolled out for global consumption, particularly to poorer countries, under the WHO's program COVAX. However, it is important that people aged 16 or over in the identified area take a Covid-19 test as directed.

William said due to logistical purposes around the arrival of the vaccines this evening, no media access can be granted. Johnson & Johnson's vaccine has a 57 percent against the South African variant.

In the eastern French region that has seen a surge in suspected variant cases, union representative Monique François said Monday that only a few health workers appeared to have signed up to receive the AstraZeneca vaccine. That is almost three times the amount that EU members are paying for the same vaccine, according to information leaked by European officials. The South African variant has also been infecting the younger population more.

AstraZeneca says it believes its two-dose vaccine protectsagainst severe COVID-19 and that it has started adapting it tobe more effective against the 501Y.V2 variant.

UK strain 187 cases of UK variant confirmed in India
UK strain 187 cases of UK variant confirmed in India

"Critically, an additional 500 000 doses are expected to arrive over the next four weeks, supplemented by another 20-million doses of the Pfizer vaccine that [are] expected to be received at the end of March", Mkhize said.

And what of that huge stockpile of AstraZeneca vaccines?

The Ministry added that more than 88.5 lakh COVID19 vaccine doses have been administered so far and more than 1.3 lakh vaccine doses were given on Tuesday.

They will distribute to the countries that have already indicated interest.

The Johnson & Johnson vaccine will be the first to be used as it is shown by a large global clinical trial to be effective in offering protection from the variant that is now dominant in South Africa, he said. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.


Melbourne lockdown to end after quarantine outbreak controlled